132 related articles for article (PubMed ID: 38580782)
1. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
Xu K; Nacheva E
J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
[TBL] [Abstract][Full Text] [Related]
2. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract][Full Text] [Related]
3. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
Cytometry B Clin Cytom; 2015 Jan; 88(1):69-73. PubMed ID: 24715427
[TBL] [Abstract][Full Text] [Related]
4. Plasma cell leukaemia mimicking acute monocytic leukaemia in the course of multiple myeloma.
Eclache V; Lusina D; Lejeune F; Casassus P; Smadja N; Lortholary P
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):419-22. PubMed ID: 8414961
[TBL] [Abstract][Full Text] [Related]
5. [Acute plasmablastic leukemia in multiple myeloma].
Solov'eva EA; Kruglova GV; Frenkel' MA; Drugush EK
Ter Arkh; 1986; 58(9):36-40. PubMed ID: 3787488
[TBL] [Abstract][Full Text] [Related]
6. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Rajkumar SV; Fonseca R; Lacy MQ; Witzig TE; Therneau TM; Kyle RA; Litzow MR; Gertz MA; Greipp PR
J Clin Oncol; 1999 May; 17(5):1551-7. PubMed ID: 10334543
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
Song S; Zhang J; Su Q; Zhang W; Jiang Y; Fan G; Qian C; Li B; Zhuang W
Br J Cancer; 2021 May; 124(11):1843-1853. PubMed ID: 33785876
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell morphology in multiple myeloma and related disorders.
Ribourtout B; Zandecki M
Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
[TBL] [Abstract][Full Text] [Related]
9. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
Klug S; Höltermann F; Fritsch H
Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.
Møller HE; Preiss BS; Pedersen P; Kristensen IB; Hansen CT; Frederiksen M; Abildgaard N; Møller MB
APMIS; 2015 Aug; 123(8):652-8. PubMed ID: 26152595
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell leukemia: from biology to treatment.
Jelinek T; Kryukov F; Rihova L; Hajek R
Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
[TBL] [Abstract][Full Text] [Related]
12. [80-year-old patient with dyspnoea, back ache and peripheral oedema. Plasma cell leukemia in multiple myeloma].
Austein T; Demme B
Dtsch Med Wochenschr; 2010 Nov; 135(44):2187-8. PubMed ID: 20979004
[No Abstract] [Full Text] [Related]
13. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
Alghasham N; Alnounou R; Alzahrani H; Alsharif F
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P
Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276
[TBL] [Abstract][Full Text] [Related]
15. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
[TBL] [Abstract][Full Text] [Related]
16. Plasmablastic transformation of multiple myeloma.
Lee CK; Ma ES; Shek TW; Lam CC; Au WY; Wan TS; Chan LC
Hum Pathol; 2003 Jul; 34(7):710-4. PubMed ID: 12874768
[TBL] [Abstract][Full Text] [Related]
17. Primary plasma cell leukaemia.
Sabharwal BD; Aggarwal SP; Chander K; Duggal A
J Assoc Physicians India; 1991 May; 39(5):410-1. PubMed ID: 1960162
[No Abstract] [Full Text] [Related]
18. [A case of plasma cell leukemia. Clinical and cytogenetic observations].
Balogh E; Fleischmann T; Krizsa F
Orv Hetil; 1985 Oct; 126(41):2531-3. PubMed ID: 3863083
[No Abstract] [Full Text] [Related]
19. Aggressive and extramedullary plasma cell myeloma evade bone marrow flow cytometric minimal residual disease detection.
Came N; Nguyen V; Westerman D; Harrison S
Br J Haematol; 2016 Jun; 173(6):947-9. PubMed ID: 26456706
[No Abstract] [Full Text] [Related]
20. Secondary plasma cell leukemia.
Rotaru I; Găman G; Dumitrescu D; Foarfă C
Rom J Morphol Embryol; 2012; 53(4):1073-6. PubMed ID: 23303035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
